| Ident. | Authors (with country if any) | Title |
|---|
| 001853 (2013) |
Natalie L. Mccarthy [États-Unis] ; Julianne Gee [États-Unis] ; Nancy D. Lin [États-Unis] ; Veena Thyagarajan [États-Unis] ; YI PAN [États-Unis] ; SUE SU [États-Unis] ; Bruce Turnbull [États-Unis] ; K. Arnold Chan [Taïwan] ; Eric Weintraub [États-Unis] | Evaluating the safety of influenza vaccine using a claims-based health system |
| 001864 (2013) |
Allen C. Bateman [États-Unis] ; Burney A. Kieke [États-Unis] ; Stephanie A. Irving [États-Unis] ; Jennifer K. Meece [États-Unis] ; David K. Shay [Géorgie] ; Edward A. Belongia [États-Unis] | Effectiveness of Monovalent 2009 Pandemic Influenza A Virus Subtype H1N1 and 2010- 2011 Trivalent Inactivated Influenza Vaccines in Wisconsin During the 2010-2011 Influenza Season |
| 001877 (2013) |
YO HAN JANG [Corée du Sud] ; YOUNG HO BYUN [Corée du Sud] ; Dong-Hun Lee [Corée du Sud] ; Kwang-Hee Lee [Corée du Sud] ; YOON JAE LEE [Corée du Sud] ; YUN HA LEE [Corée du Sud] ; Jae-Keun Park [Corée du Sud] ; Chang-Seon Song [Corée du Sud] ; BAIKLIN SEONG [Corée du Sud] | Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets |
| 001888 (2013) |
Jennifer L. Nayak [États-Unis] ; Theresa F. Fitzgerald [États-Unis] ; Katherine A. Richards [États-Unis] ; HONGMEI YANG [États-Unis] ; John J. Treanor [États-Unis] ; Andrea J. Sant [États-Unis] | CD4+ T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine |
| 001893 (2013) |
MINSOO JUNG [États-Unis, Corée du Sud] ; Leesa Lina [États-Unis] ; K. Viswanath [États-Unis] | Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents' H1N1 vaccination of their children |
| 001901 (2013) |
Silvia Candela [Italie] ; Sara Pergolizzi [Italie] ; Pietro Ragni [Italie] ; Silvio Cavuto [Italie] ; Lucia Nobilio [Italie] ; Simona Di Mario [Italie] ; Valentina Dragosevic [Italie] ; Nicola Groth [Italie] ; Nicola Magrini [Italie] | An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria® in a province of Emilia-Romagna region, Italy - Part One |
| 001903 (2013) |
Sinthujan Jegaskanda [Australie] ; Karen L. Laurie [Australie] ; Thakshila H. Amarasena [Australie] ; Wendy R. Winnall [Australie] ; Marit Kramski [Australie] ; Robert De Rose [Australie] ; Ian G. Barr [Australie] ; Andrew G. Brooks [Australie] ; Patrick C. Reading [Australie] ; Stephen J. Kent [Australie] | Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1 |
| 001911 (2013) |
Maria Luisa Moro [Italie] ; Lucia Nobilio [Italie] ; Claudio Voci [Italie] ; Simona Di Mario [Italie] ; Silvia Candela [Italie] ; Nicola Magrini [Italie] | A population based cohort study to assess the safety of pandemic influenza vaccine Focetria® in Emilia-Romagna region, Italy-Part Two |
| 001913 (2013) |
Matthew S. Miller [États-Unis] ; Tshidi Tsibane [États-Unis] ; Florian Krammer [États-Unis] ; RONG HAI [États-Unis] ; Saad Rahmat [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Pales [États-Unis] | 1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans |
| 001E64 (2012) |
Damus P. Kouassi [Côte d'Ivoire] ; Daouda Coulibaly [Côte d'Ivoire] ; Lydia Foster [Géorgie] ; Herve Kadjo [Côte d'Ivoire] ; Talla N'Zussuouo [Géorgie, Égypte, Ghana] ; Youssouf Traore [Côte d'Ivoire] ; Djibril Cherif [Côte d'Ivoire] ; Anderson K. N'Gattia [Côte d'Ivoire] ; Mark G. Thompson [Géorgie] | Vulnerable Groups Within a Vulnerable Population: Awareness of the A(H1N1)pdm09 Pandemic and Willingness to Be Vaccinated Among Pregnant Women in Ivory Coast |
| 001E65 (2012) |
B. Olowokure [Royaume-Uni] ; O. Odedere [Royaume-Uni] ; A. J. Elliot [Royaume-Uni] ; A. Awofisayo [Royaume-Uni] ; E. Smit [Royaume-Uni] ; A. Fleming [Royaume-Uni] ; H. Osman [Royaume-Uni] | Volume of print media coverage and diagnostic testing for influenza A(H1N1)pdm09 virus during the early phase of the 2009 pandemic |
| 001E71 (2012) |
Loreto Fuenzalida [Espagne] ; Cristina Prat [Espagne] ; Silvia Blanco [Espagne] ; Albert Bas [Espagne] ; M. J. Dominguez [Espagne] ; M. Angeles Hernandez [Espagne] ; Carlos Rodrigo [Espagne] ; Vicente Ausina [Espagne] | Validation of a polymerase chain reaction-oligochromatography test for detection of influenza A (H1N1) 2009 virus |
| 001E80 (2012) |
L. Ponnambalam [Singapour] ; L. Samavedham [Singapour] ; H. R. Lee [Singapour] ; C. S. Ho [Singapour] | Understanding the socioeconomic heterogeneity in healthcare in US counties: the effect of population density, education and poverty on H1N1 pandemic mortality |
| 001F07 (2012) |
Roman Seyer [France] ; Eike R. Hrincius [France] ; Dorothea Ritzel [Allemagne] ; Marion Abt [Allemagne] ; Alexander Mellmann [Allemagne] ; Henju Marjuki [États-Unis] ; Joachim Kühn [Allemagne] ; Thorsten Wolff [Allemagne] ; Stephan Ludwig [France] ; Christina Ehrhardt [France] | Synergistic Adaptive Mutations in the Hemagglutinin and Polymerase Acidic Protein Lead to Increased Virulence of Pandemic 2009 H1N1 Influenza A Virus in Mice |
| 001F19 (2012) |
Undine Ott [Allemagne] ; Andreas Sauerbrei [Allemagne] ; Jeannette Lange [Allemagne] ; Anna Sch Fler [Allemagne] ; Mario Walther [Allemagne] ; Gunter Wolf [Allemagne] ; Peter Wutzler [Allemagne] ; Roland Zell [Allemagne] ; Andi Krumbholz [Allemagne] | Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients |
| 001F28 (2012) |
Prasad S. Kulkarni [Inde] ; K. Manjunath [Inde] ; Sharad Agarkhedkar [Inde] | Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children |
| 001F31 (2012) |
Sharon E. Frey [États-Unis] ; David I. Bernstein [États-Unis] ; Michael A. Gerber [États-Unis] ; Harry L. Keyserling [Géorgie] ; Flor M. Munoz [États-Unis] ; Patricia L. Winokur [États-Unis] ; Christine B. Turley [États-Unis] ; Richard E. Rupp [États-Unis] ; Heather Hill [États-Unis] ; Mark Wolff [États-Unis] ; Diana L. Noah [États-Unis] ; Allison C. Ross [Géorgie] ; Gretchen Cress [États-Unis] ; Robert B. Belshe [États-Unis] | Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations |
| 001F51 (2012) |
K. H. Chan [Hong Kong] ; K. M. Chan [Hong Kong] ; Y. L. Ho [Hong Kong] ; Y. P. Lam [Hong Kong] ; H. L. Tong [Hong Kong] ; L. L. M. Poon [Hong Kong] ; B. J. Cowling [Hong Kong] ; J. S. M. Peiris [Hong Kong] | Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza |
| 001F68 (2012) |
Elodie Ghedin [États-Unis] ; Edward C. Holmes [États-Unis] ; Jay V. Depasse [États-Unis] ; Lady Tatiana Pinilla [Canada] ; Adam Fitch [États-Unis] ; Marie-Eve Hamelin [Canada] ; Jesse Papenburg [Canada] ; Guy Boivin [Canada] | Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and Transmission |
| 001F69 (2012) |
Rebecca L. Forbes [Australie] ; Peter A. B. Wark [Australie] ; Vanessa E. Murphy [Australie] ; Peter G. Gibson [Australie] | Pregnant Women Have Attenuated Innate Interferon Responses to 2009 Pandemic Influenza A Virus Subtype H1N1 |
| 001F88 (2012) |
Kevin Y. Njabo [États-Unis] ; Trevon L. Fuller [États-Unis] ; Anthony Chasar [États-Unis] ; John P. Pollinger [États-Unis] ; Giovanni Cattoli [Italie] ; Calogero Terregino [Italie] ; Isabella Monne [Italie] ; Jean-Marc Reynes [Cameroun] ; Richard Njouom [Cameroun] ; Thomas B. Smith [États-Unis] | Pandemic A/H1N1/2009 influenza virus in Swine, Cameroon, 2010 |
